The diagnostic significance of NT-proBNP and troponin I in emergency department patients presenting with palpitations
AUTOR(ES)
Ocak, Tarık, Erdem, Alim, Duran, Arif, TekelioÄŸlu, Ümit YaÅŸar, Öztürk, Serkan, Ayhan, Suzi Selim, Özlü, Mehmet Fatih, Tosun, Mehmet, KoçoÄŸlu, Hasan, Yazıcı, Mehmet
FONTE
Clinics
DATA DE PUBLICAÇÃO
2013-04
RESUMO
OBJECTIVE: This prospective study investigated the diagnostic significance of the N-terminal pro-brain natriuretic (NT-proBNP) and troponin I peptides in emergency department patients presenting with palpitations. METHODS: Two groups of patients with palpitations but without documented supraventricular tachycardia were compared: a group with supraventricular tachycardia (n = 49) and a control group (n = 47). Both groups were diagnosed using electrophysiological studies during the study period. Blood samples were obtained from all of the patients to determine the NT-proBNP and troponin I levels within the first hour following arrival in the emergency department. RESULT: The mean NT-proBNP levels were 207.74±197.11 in supraventricular tachyarrhythmia group and 39.99±32.83 pg/mL in control group (p<0.001). To predict supraventricular tachycardia, the optimum NT-proBNP threshold was 61.15 pg/mL, as defined by the receiver operating characteristic (ROC) curve, with a non-significant area under the ROC curve of 0.920 (95% CI, 0.86-0.97, p<0.001). The NT-proBNP cut-off for diagnosing supraventricular tachycardia had 81.6% sensitivity and 91.5% specificity. Supraventricular tachycardia was significantly more frequent in the patients with NT-proBNP levels ≥61.15 pg/mL (n = 44, 90.9%, p>0.001). The mean troponin I levels were 0.17±0.56 and 0.01±0.06 pg/mL for the patients with and without supraventricular tachycardia, respectively (p<0.05). Of the 96 patients, 21 (21.87%) had troponin I levels ≥0.01: 2 (4.25%) in the control group and 19 (38.77%) in the supraventricular tachycardia group (p<0.001). CONCLUSION: Troponin I and, in particular, NT-proBNP peptide were helpful for differentiating supraventricular tachycardia from non- supraventricular tachycardia palpitations. Further randomized, large, multicenter trials are needed to define the benefit and diagnostic role of NT-proBNP and troponin I in the management algorithm of patients presenting with palpitations in emergency departments.
Documentos Relacionados
- Admission NT-ProBNP in Myocardial Infarction: an Alert Sign?
- Prognostic value of natriuretic peptides BNP and NT-proBNP in risk stratification of patients with severe aortic stenosis
- NT-ProBNP e hipertensão arterial pulmonar em esclerose sistêmica
- Variability of NT‐proBNP levels in heart failure: implications for clinical application
- Variability of NT‐proBNP plasma and urine levels in patients with stable heart failure: a 2‐year follow‐up study